Trials / Completed
CompletedNCT01968005
Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of Etoreat®(Etodolac-Lidocaine Topical Patch) in the Treatment of Acute Low Back Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 232 (actual)
- Sponsor
- MEDRx USA, Inc. · Industry
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate efficacy, tolerability and safety of Etoreat®(Etodolac-Lidocaine Topical Patch) in the treatment of acute low back pain (LBP).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etoreat®(Etodolac-Lidocaine Topical Patch) | |
| DRUG | Placebo |
Timeline
- Start date
- 2013-11-01
- Primary completion
- 2014-05-01
- Completion
- 2014-11-01
- First posted
- 2013-10-23
- Last updated
- 2018-01-17
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01968005. Inclusion in this directory is not an endorsement.